BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12924084)

  • 21. A case of hydroxyurea-induced leg ulcer after definitive treatment suspension in a patient affected by thrombocythemia: effectiveness of a new collagenase.
    Fioramonti P; Fino P; Parisi P; Scuderi N; Onesti MG
    In Vivo; 2012; 26(6):1053-6. PubMed ID: 23160693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leg ulcers associated with hydroxyurea therapy.
    Sastre JL; Bravo A; Tembrás S; Gómez R; Ulibarrena C
    Haematologica; 2003 Feb; 88(2):EIM01. PubMed ID: 12604429
    [No Abstract]   [Full Text] [Related]  

  • 23. Hydroxyurea-induced ulcers on the leg.
    Dissemond J; Körber A
    CMAJ; 2009 May; 180(11):1132. PubMed ID: 19468123
    [No Abstract]   [Full Text] [Related]  

  • 24. [A lower-leg ulcer during hydroxyurea therapy for essential thrombocythemia].
    Iwama H; Kawakubo K; Nehashi Y; Kuriyama Y; Iwase O; Ohyashiki K; Watanabe K; Ebihara Y; Toyama K
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):937-9. PubMed ID: 8678547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Painful leg ulcers and a rash in a patient with polycythaemia rubra vera. Diagnosis: hydroxyurea-induced leg ulceration and dermatomyositis-like skin changes.
    Haniffa MA; Speight EL
    Clin Exp Dermatol; 2006 Sep; 31(5):733-4. PubMed ID: 16901329
    [No Abstract]   [Full Text] [Related]  

  • 26. Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy.
    Leo E; Krämer A; Hochhaus A; Krasniqi F; Hehlmann R; Ho AD
    Ann Hematol; 2002 Aug; 81(8):467-9. PubMed ID: 12224005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
    Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
    Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Myeloid Leukaemia with Sudden Bilateral Deafness and Leg Ulcer Associated with Hydroxyurea Therapy.
    Ugwu NI; Okoye AE; Ugwu CN; Ibiam FA; Nnachi OA; Ugwu GC; Okoh NU
    West Afr J Med; 2021 May; 38(5):502-506. PubMed ID: 34051725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
    Vaiopoulos G; Terpos E; Viniou N; Nodaros K; Rombos J; Loukopoulos D
    Am J Hematol; 2001 Jan; 66(1):57-8. PubMed ID: 11426495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxyurea-induced leg ulcers treated with a protease-modulating matrix.
    Romanelli M; Dini V; Romanelli P
    Arch Dermatol; 2007 Oct; 143(10):1310-3. PubMed ID: 17938346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxyurea-induced leg ulcers treated with Apligraf.
    Flores F; Eaglstein WA; Kirsner RS
    Ann Intern Med; 2000 Mar; 132(5):417-8. PubMed ID: 10691597
    [No Abstract]   [Full Text] [Related]  

  • 32. Cost-utility analysis of imatinib mesylate for the treatment of chronic myelogenous leukemia in the chronic phase.
    Warren E; Ward S; Gordois A; Scuffham P
    Clin Ther; 2004 Nov; 26(11):1924-33. PubMed ID: 15639704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anagrelide is effective in treating patients with hydroxyurea-resistant thrombocytosis in patients with chronic myeloid leukemia.
    Silver RT
    Leukemia; 2005 Jan; 19(1):39-43. PubMed ID: 15510207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leg ulcer in a patient associated with hydroxyurea therapy.
    Dissemond J; Hoeft D; Knab J; Franckson T; Kroger K; Goos M
    Int J Dermatol; 2006 Feb; 45(2):158-60. PubMed ID: 16445510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombocytosis--report of a case.
    Thomas M; Pavithran K; Salil ; Somarajan A
    J Assoc Physicians India; 2000 Apr; 48(4):441-2. PubMed ID: 11273186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leg ulcer associated with hydroxyurea treatment in a patient with chronic myelogenous leukaemia: successful treatment with prostagladin E1 and pentoxifylline.
    Kido M; Tago O; Fujiwara H; Ito M; Niwano H
    Br J Dermatol; 1998 Dec; 139(6):1124-6. PubMed ID: 9990395
    [No Abstract]   [Full Text] [Related]  

  • 37. Leg ulceration with associated thrombocytosis: healing of ulceration associated with treatment of the raised platelet count.
    Varma S; Lanigan SW
    Br J Dermatol; 1999 Jan; 140(1):188-9. PubMed ID: 10215806
    [No Abstract]   [Full Text] [Related]  

  • 38. Hydroxyurea-related ankle ulcers in patients with myeloproliferative disorders: a case report and review of the literature.
    Cox C; Nowicky D; Young R
    Ann Plast Surg; 1997 Nov; 39(5):546-9. PubMed ID: 9374154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease.
    Chaine B; Neonato MG; Girot R; Aractingi S
    Arch Dermatol; 2001 Apr; 137(4):467-70. PubMed ID: 11295927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Painful symmetrical ankle ulcerations. A 73-year old patient with chronic myeloid leukemia].
    Welt K; Ott S; Weiss JM; Scharffetter-Kochanek K
    Hautarzt; 2004 Feb; 55(2):190-3. PubMed ID: 14968332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.